Silence Therapeutics plc (SLN) stock
SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF
$19.80+0.00 (0.00%)
Close on Nov 17, 2026Market cap $935.48MP/E –Yield –
Silence Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Silence Therapeutics's price to book ratio was 24.3× on Nov 11, 2026, against 4.3× a year earlier. Over the last 5 years it ranged from 1.0× to 45.9×, with a median of 13.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 24.3× | +20.4 |
| 2025 | Dec 31, 2025 | 3.9× | −8.5 |
| 2024 | Dec 31, 2024 | 12.4× | −10.5 |
| 2023 | Dec 29, 2023 | 22.9× | −13.6 |
| 2022 | Dec 30, 2022 | 36.5× | – |
See a number that looks wrong?